FIA
ABBV icon

Foundations Investment Advisors’s AbbVie ABBV Stock Holding History

Foundations Investment Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12M Sell
47,824
-17,455
-27% -$3.76M 0.12% 159
2026
Q1 		$14.2M Buy
65,279
+20,750
+47% +$4.6M 0.18% 130
2025
Q4 		$10.2M Buy
44,529
+17,436
+64% +$3.97M 0.13% 146
2025
Q3 		$6.27M Buy
27,093
+2,180
+9% +$444K 0.09% 172
2025
Q2 		$4.62M Buy
24,913
+2,346
+10% +$436K 0.07% 214
2025
Q1 		$4.73M Buy
22,567
+1,828
+9% +$355K 0.09% 205
2024
Q4 		$3.69M Sell
20,739
-44,138
-68% -$8.12M 0.07% 214
2024
Q3 		$12.8M Buy
64,877
+28,641
+79% +$5.35M 0.27% 85
2024
Q2 		$6.22M Buy
36,236
+2,901
+9% +$481K 0.15% 120
2024
Q1 		$6.07M Sell
33,335
-300
-0.9% -$51.7K 0.16% 116
2023
Q4 		$5.64M Sell
33,635
-1,826
-5% -$266K 0.15% 110
2023
Q3 		$5.29M Buy
35,461
+1,743
+5% +$256K 0.16% 106
2023
Q2 		$4.54M Sell
33,718
-1,999
-6% -$293K 0.15% 99
2023
Q1 		$5.69M Buy
35,717
+8,013
+29% +$1.23M 0.2% 78
2022
Q4 		$4.48M Buy
27,704
+14,871
+116% +$2.28M 0.18% 72
2022
Q3 		$1.72M Buy
12,833
+4,823
+60% +$692K 0.08% 113
2022
Q2 		$1.22M Buy
8,010
+1,738
+28% +$266K 0.05% 121
2022
Q1 		$1.02M Buy
6,272
+93
+2% +$13.5K 0.04% 127
2021
Q4 		$848K Sell
6,179
-292
-5% -$34.5K 0.03% 139
2021
Q3 		$709K Buy
6,471
+275
+4% +$31.4K 0.03% 139
2021
Q2 		$722K Sell
6,196
-579
-9% -$65.2K 0.03% 124
2021
Q1 		$713K Buy
6,775
+545
+9% +$58.3K 0.04% 108
2020
Q4 		$668K Buy
6,230
+652
+12% +$62.7K 0.04% 95
2020
Q3 		$480K Sell
5,578
-403
-7% -$37.9K 0.11% 112
2020
Q2 		$591K Buy
5,981
+2,808
+88% +$247K 0.05% 95
2020
Q1 		$233K Buy
3,173
+580
+22% +$49.4K 0.03% 102
2019
Q4 		$232K Buy
+2,593
New +$215K 0.03% 119

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Foundations Investment Advisors's ABBV Position: Q2 2026 in Review

Foundations Investment Advisors reduced its AbbVie (ABBV) stake by 27% in Q2 2026, selling an estimated $3.76M and leaving 47,824 shares worth $12M. The position accounts for 0.12% of the portfolio, ranked #159.

Foundations Investment Advisors first reported a position in ABBV in Q4 2019 and has held it in 27 quarters since. The position peaked at $14.2M in Q1 2026. 4,190 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Foundations Investment Advisors held 47,824 shares of AbbVie worth $12M as of Q2 2026.
  • Foundations Investment Advisors sold 17,455 AbbVie shares in Q2 2026, an estimated $3.76M.
  • AbbVie made up 0.12% of Foundations Investment Advisors's portfolio in Q2 2026, its #159 holding.
  • Foundations Investment Advisors first reported a position in AbbVie in Q4 2019 and has held it in 27 quarters since.
  • Foundations Investment Advisors's AbbVie position peaked at $14.2M in Q1 2026.
  • 4,190 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Foundations Investment Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.